Lombard Medical Company Profile (NASDAQ:EVAR)

Analyst Ratings

Consensus Ratings for Lombard Medical (NASDAQ:EVAR) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $5.17 (323.50% upside)

Analysts' Ratings History for Lombard Medical (NASDAQ:EVAR)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2016BTIG ResearchReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015Barclays PLCDowngradeOverweight -> Equal Weight$5.00 -> $2.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015Jefferies GroupLower Price TargetBuy$7.50 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Credit Suisse Group AGLower Price TargetOutperform$10.50 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Lombard Medical (NASDAQ:EVAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
5/11/2016Q1($0.41)($0.38)$3.52 million$2.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2016Q415($0.40)($0.58)$3.25 million$2.94 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.53)($0.45)$4.65 million$4.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2015Q215($0.55)($0.51)$4.46 million$4.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q1145($0.57)($0.59)$3.20 million$3.41 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q4($0.58)($0.51)$4.80 million$4.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q314($0.79)($0.52)$2.14 million$4.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.52)($0.86)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Lombard Medical (NASDAQ:EVAR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.49)($0.39)($0.44)
Q2 20162($0.40)($0.39)($0.40)
Q3 20162($0.40)($0.39)($0.40)
Q4 20162($0.41)($0.41)($0.41)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Lombard Medical (NASDAQ:EVAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Lombard Medical (NASDAQ:EVAR)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Lombard Medical (NASDAQ:EVAR)
DateHeadline
07/06/16 05:11 AMLombard Medical Expands European Launch of its New Altura® Endograft System - [at noodls] - IRVINE, Calif., July 06, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
07/03/16 08:29 AMCompany Stock Lower on the Week Lombard Medical, Inc. (NASDAQ:EVAR) - Engelwood Daily
07/01/16 08:57 PMSell-Side Recommendation & Price Target Projections on Lombard Medical, Inc. (NASDAQ:EVAR) - Telanagana Press
07/01/16 03:54 PMIntelliFlex LP’s Lower Catheter Profile Expands Aorfix Treatment to More Patients
06/30/16 09:22 PMIntelliFlex LP's Lower Catheter Profile Expands Aorfix Treatment to More Patients
06/30/16 04:09 PMRecently Issued Stock Ratings For Lombard Medical, Inc. (EVAR) - Fiscal Standard
06/30/16 06:30 AMLombard Medical Announces First Commercial Use of its New IntelliFlex™ LP Delivery System for the Aorfix ... - GlobeNewswire (press release)
06/30/16 06:30 AMLombard Medical, Inc. (NASDAQ:EVAR) Company Rating and Target Watch - Telanagana Press
06/30/16 05:11 AMLombard Medical Announces First Commercial Use of its New IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft - [at noodls] - IRVINE, Calif., June 30, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/29/16 06:28 AMShare Update and Earnings Review for Lombard Medical, Inc. (NASDAQ:EVAR) - Press Telegraph
06/28/16 08:55 PMToday's Stocks: Lombard Medical, Inc. (NASDAQ:EVAR), Oracle Corporation (NYSE:ORCL), Autohome Inc. (NYSE ... - KC Register
06/28/16 08:55 PMLombard Medical, Inc. (NASDAQ:EVAR) Earnings Glance and Target Price Review - Engelwood Daily
06/28/16 08:55 PMStock Volatility in Review: Lombard Medical, Inc. (NASDAQ:EVAR) - Engelwood Daily
06/28/16 08:55 PMNext Weeks Broker Price Targets For Lombard Medical, Inc. (EVAR) - Fiscal Standard
06/20/16 03:47 PMNew, Innovative Design Enhances Control and Precision During Placement with the Potential to Reduce Vessel Trauma
06/20/16 11:39 AMLombard Medical Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft - [at noodls] - IRVINE, Calif., June 20, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/16/16 08:16 AMPaul Hayes, MD, FRCS, Endovascular Surgeon, University of Cambridge and Addenbrookes Hospital, Appointed as Principal Investigator
06/16/16 07:39 AMLombard Medical to Initiate the Altura® ALTITUDE Global Registry to Evaluate the Treatment of Abdominal Aortic Aneurysms Across a Wide Range of “Real-World” Endovascular Aneurysm Repair Interventions - [at noodls] - IRVINE, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/13/16 05:09 AMLombard Medical Reports Positive Five-Year Aorfix™ Endovascular Stent Graft Clinical Results in AAA Patients with Challenging Anatomy - [at noodls] - IRVINE, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/09/16 07:27 AMLombard Medical (EVAR) Offers Commercial Update on Altura Endovascular Stent Graft System
06/08/16 05:10 AM6:10 am Lombard Medical provides update on Altura Endovascular Stent Graft System, EU launch planned in 3Q16, long-term clinical data to be released in second half of 2016 -
06/08/16 05:08 AMLombard Medical Provides Update on Controlled Launch of the New Altura® Endovascular Stent Graft in Europe - [at noodls] - IRVINE, Calif., June 08, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/07/16 04:00 PMLombard Medical to Present at the Jefferies 2016 Healthcare Conference - GlobeNewswire (press release)
06/07/16 01:18 PMLombard Medical to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - IRVINE, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/06/16 03:47 PMLombard Medical, Inc. (NASDAQ:EVAR) surged 7.87%: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI), EP Energy ... - KC Register
06/06/16 03:47 PMAT&T, Inc. (NYSE:T) Went Up 0.95%: Lombard Medical, Inc. (NASDAQ:EVAR), Exelixis, Inc. (NASDAQ:EXEL), Meredith ... - KC Register
06/06/16 05:08 AMLombard Medical Receives Australian Therapeutic Goods Administration (TGA) Approval for the Aorfix™ Endovascular Stent Graft for the Treatment of Abdominal Aortic Aneurysms - [at noodls] - IRVINE, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/05/16 03:51 PMAfter Last Week What Do Analysts Think Of Lombard Medical, Inc. (EVAR) - Share Trading News
06/02/16 04:03 PMLombard Medical Inc.: Lombard Medical Announces Scientific Presentation on Aorfix™ Endovascular Stent Graft Five ... - The Wall Street Transcript - Lombard Medical Inc.: Lombard Medical Announces Scientific Presentation on Aorfix™ Endovascular Stent Graft Five ...The Wall Street TranscriptIRVINE, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that its Aorfix™ ...Lombard Medical Ord (NASDAQ:EVAR) Shorted Shares Increased 33.38% After Market SellingHNNall 3 news articles »
06/02/16 06:54 AMLombard Medical (EVAR) to Present Aorfix Endovascular Stent Graft Data at SVS Annual Meeting - StreetInsider.com - Lombard Medical (EVAR) to Present Aorfix Endovascular Stent Graft Data at SVS Annual MeetingStreetInsider.comLombard Medical, Inc. (Nasdaq: EVAR) announced that its Aorfix Endovascular Stent Graft will be featured in a scientific presentation at the 2016 Vascular Annual Meeting of the Society for Vascular Surgery (SVS) to be held at the Gaylord National ...and more »
06/02/16 05:05 AMLombard Medical Announces Scientific Presentation on Aorfix™ Endovascular Stent Graft Five-Year Clinical Data at the 2016 Society for Vascular Surgery Annual Meeting - [at noodls] - IRVINE, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
06/01/16 10:11 PMBroker Watchlist: Lombard Medical, Inc. (EVAR) - Share Trading News - Broker Watchlist: Lombard Medical, Inc. (EVAR)Share Trading News01/20/2015 – Lombard Medical, Inc. had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 8 price target on the stock. The share price of Lombard Medical, Inc. (EVAR) was up +0.00% during the last trading session, with ...
06/01/16 07:19 AMStock Review and Earnings Check on Lombard Medical, Inc. (NASDAQ:EVAR) - HNN - Stock Review and Earnings Check on Lombard Medical, Inc. (NASDAQ:EVAR)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Lombard Medical, Inc. (NASDAQ:EVAR) to report quarterly EPS of $-0.39. The company's next earnings report is expected to be published on ...and more »
05/31/16 10:19 AMLombard Medical Inc.: Lombard Medical Announces Scientific Presentation by Leading Japanese Surgeons on ... - The Wall Street Transcript - Lombard Medical Inc.: Lombard Medical Announces Scientific Presentation by Leading Japanese Surgeons on ...The Wall Street TranscriptIRVINE, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that its Aorfix™ ...and more »
05/31/16 05:22 AMLombard Medical Announces Scientific Presentation by Leading Japanese Surgeons on Improving Endovascular Aneurysm Repair (EVAR) Treatment using the Aorfix™ Endovascular Stent Graft at the 2016 Japanese Society for Vascular Surgery Annual Me - [at noodls] - IRVINE, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
05/30/16 12:38 PMNext Weeks Broker Price Targets For Lombard Medical, Inc. (EVAR) - Share Trading News - Next Weeks Broker Price Targets For Lombard Medical, Inc. (EVAR)Share Trading NewsLombard Medical, Inc. has a 50 day moving average of 1.49 and a 200 day moving average of 1.24. The stock's market capitalization is 27.44M, it has a 52-week low of 0.55 and a 52-week high of 5.88. The share price of the company (EVAR) was down ...
05/26/16 10:48 AMHold Calls Count For Lombard Medical, Inc. (NASDAQ:EVAR) At 1 - Investor Newswire - Hold Calls Count For Lombard Medical, Inc. (NASDAQ:EVAR) At 1Investor NewswireLombard Medical, Inc. (NASDAQ:EVAR) has a total of 2 Strong Buy recommendations and 0 Strong Sell advises as of 2016-05-24. The rating procedure used by Zacks gives scores to firms on a narrow 1-5 scale. A score close to 1-2 band is a Buy call, a score ...and more »
05/19/16 05:52 AMLombard Medical Announces Scientific Presentation on Altura® and Aorfix™ Endovascular Stent Grafts at the International Symposium on Endovascular Therapeutics, SITE Update 2016 - [at noodls] - IRVINE, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
05/17/16 03:00 PMEVAR: Altura Feedback Positive, Resources Shifted to Support Launch -
05/17/16 01:41 PMLombard Medical, Inc. :EVAR-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 05:32 AMLombard Medical Releases Positive Early Results from the Altura® Endograft System Clinical Evaluation - [at noodls] - IRVINE, Calif., May 17, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
05/11/16 04:07 PMLombard Medical Reports 2016 First Quarter Financial Results - [at noodls] - IRVINE, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
05/11/16 03:52 PMLombard Medical reports 1Q loss -
05/11/16 06:07 AMQ1 2016 Lombard Medical Inc Earnings Release - After Market Close -
05/03/16 05:10 AMLombard Medical Announces 2016 First Quarter Financial Results Release and Conference Call Date - [at noodls] - IRVINE, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced ...
04/21/16 05:08 AMLombard Medical Announces Scientific Presentations on Altura® and Aorfix™ Endovascular Stent Grafts at the 38th Annual Charing Cross International Symposium - [at noodls] - IRVINE, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today ...
03/09/16 07:38 AMLombard Medical Completes First Altura® Endovascular Stent Graft Live Case Physician Training Workshop - [GlobeNewswire] - IRVINE, Calif., March 09, 2016-- Lombard Medical, Inc., a medical device company focused on Endovascular Repair of abdominal aortic aneurysms, today announced that the first Altura ® Endovascular Stent ...
03/03/16 05:00 AMLombard Medical’s New Altura® Endovascular Stent Graft to be Presented at 9th Annual Houston Aortic Symposium - [GlobeNewswire] - IRVINE, Calif., March 03, 2016-- Lombard Medical, Inc., a medical device company focused on Endovascular Repair of abdominal aortic aneurysms, today announced that Dainis Krievins, MD, PhD, Professor of ...
02/26/16 03:01 PMLombard Medical Receives NASDAQ Notice of Bid Price Deficiency - [GlobeNewswire] - IRVINE, Calif., Feb. 26, 2016-- Lombard Medical, Inc., a medical device company focused on Endovascular Repair of abdominal aortic aneurysms, reported that on February 24, 2016, it received a NASDAQ Staff ...
02/22/16 05:21 AMLombard Medical reports 4Q loss -

Social

About Lombard Medical

Lombard Medical logoLombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts for repair of aortic aneurysms. Its lead product, Aorfix, is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of up to 90 degrees. It supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. Its principal brands are Aorfix and Aorflex. Outside of the United States, it markets Aorfix through its direct sales forces in Germany and the United Kingdom and through distribution agreements with partners in other European Union countries, Latin America and Asia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: EVAR
  • CUSIP:
Key Metrics:
  • Previous Close: $1.22
  • 50 Day Moving Average: $1.22
  • 200 Day Moving Average: $1.15
  • P/E Ratio: N/A
  • P/E Growth: -0.02
  • Market Cap: $24.26M
  • Beta: 1.33
  • Current Year EPS Consensus Estimate: $-1.51 EPS
  • Next Year EPS Consensus Estimate: $-1.35 EPS
Additional Links:
Lombard Medical (NASDAQ:EVAR) Chart for Wednesday, July, 27, 2016